Ancora Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.5K | Hold |
657
| – | – | ﹤0.01% | 992 |
|
|
2025
Q1 | $53.3K | Hold |
657
| – | – | ﹤0.01% | 988 |
|
|
2024
Q4 | $59.2K | Sell |
657
-241
| -27% | -$21.7K | ﹤0.01% | 951 |
|
|
2024
Q3 | $88.7K | Hold |
898
| – | – | ﹤0.01% | 841 |
|
|
2024
Q2 | $83.3K | Sell |
898
-600
| -40% | -$55.6K | ﹤0.01% | 815 |
|
|
2024
Q1 | $142K | Buy |
1,498
+9
| +0.6% | +$854 | ﹤0.01% | 734 |
|
|
2023
Q4 | $133K | Sell |
1,489
-167
| -10% | -$14.9K | ﹤0.01% | 727 |
|
|
2023
Q3 | $121K | Sell |
1,656
-127
| -7% | -$9.27K | ﹤0.01% | 731 |
|
|
2023
Q2 | $148K | Hold |
1,783
| – | – | ﹤0.01% | 695 |
|
|
2023
Q1 | $136K | Hold |
1,783
| – | – | ﹤0.01% | 701 |
|
|
2022
Q4 | $148K | Buy |
1,783
+311
| +21% | +$25.8K | ﹤0.01% | 713 |
|
|
2022
Q3 | $117K | Hold |
1,472
| – | – | ﹤0.01% | 823 |
|
|
2022
Q2 | $109K | Buy |
1,472
+1,162
| +375% | +$86K | ﹤0.01% | 911 |
|
|
2022
Q1 | $28K | Sell |
310
-22
| -7% | -$1.99K | ﹤0.01% | 1427 |
|
|
2021
Q4 | $37K | Buy |
332
+84
| +34% | +$9.36K | ﹤0.01% | 1371 |
|
|
2021
Q3 | $31K | Buy |
248
+117
| +89% | +$14.6K | ﹤0.01% | 1318 |
|
|
2021
Q2 | $18K | Sell |
131
-360
| -73% | -$49.5K | ﹤0.01% | 1358 |
|
|
2021
Q1 | $67K | Sell |
491
-154
| -24% | -$21K | ﹤0.01% | 956 |
|
|
2020
Q4 | $91K | Buy |
645
+40
| +7% | +$5.64K | ﹤0.01% | 752 |
|
|
2020
Q3 | $67K | Buy |
605
+356
| +143% | +$39.4K | ﹤0.01% | 775 |
|
|
2020
Q2 | $28K | Buy |
249
+41
| +20% | +$4.61K | ﹤0.01% | 907 |
|
|
2020
Q1 | $16K | Buy |
208
+113
| +119% | +$8.69K | ﹤0.01% | 1053 |
|
|
2019
Q4 | $9K | Buy |
+95
| New | +$9K | ﹤0.01% | 1167 |
|
|
2017
Q1 | – | Sell |
-15
| Closed | -$1K | – | 1079 |
|
|
2016
Q4 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 1215 |
|